386 related articles for article (PubMed ID: 10817685)
1. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
Linden PK; Moellering RC; Wood CA; Rehm SJ; Flaherty J; Bompart F; Talbot GH;
Clin Infect Dis; 2001 Dec; 33(11):1816-23. PubMed ID: 11668430
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
Summers M; Misenhimer GR; Antony SJ
South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
[TBL] [Abstract][Full Text] [Related]
5. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Lorian V; Fernandes F
Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547
[TBL] [Abstract][Full Text] [Related]
6. Quinupristin-dalfopristin and linezolid: evidence and opinion.
Eliopoulos GM
Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
[TBL] [Abstract][Full Text] [Related]
8. Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections.
Manzella JP
Am Fam Physician; 2001 Dec; 64(11):1863-6. PubMed ID: 11764864
[TBL] [Abstract][Full Text] [Related]
9. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vancomycin-resistant Enterococcus faecium infections.
Lai KK
Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
[TBL] [Abstract][Full Text] [Related]
11. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
Werner G; Klare I; Spencker FB; Witte W
J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
[TBL] [Abstract][Full Text] [Related]
12. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans.
Kieke AL; Borchardt MA; Kieke BA; Spencer SK; Vandermause MF; Smith KE; Jawahir SL; Belongia EA;
J Infect Dis; 2006 Nov; 194(9):1200-8. PubMed ID: 17041845
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
[TBL] [Abstract][Full Text] [Related]
15. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline.
Raad I; Hachem R; Hanna H; Girgawy E; Rolston K; Whimbey E; Husni R; Bodey G
Antimicrob Agents Chemother; 2001 Nov; 45(11):3202-4. PubMed ID: 11600379
[TBL] [Abstract][Full Text] [Related]
16. Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report.
Schwenger V; Mündlein E; Dagrosa EE; Fahr AM; Zeier M; Mikus G; Andrassy K
Infection; 2002 Oct; 30(5):257-61. PubMed ID: 12382082
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
McNeil SA; Clark NM; Chandrasekar PH; Kauffman CA
Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
[No Abstract] [Full Text] [Related]
19. Case of vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunt that was treated with quinupristin/dalfopristin after bacteremia persisted with alatrofloxacin therapy.
Zaman MM; Recco R; Tejwani U; Scuto TJ; Ahmed S; Hypolite A; Jayaraman G
Clin Infect Dis; 1999 Oct; 29(4):954-5. PubMed ID: 10589932
[No Abstract] [Full Text] [Related]
20. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
